Follow the 녹십자엠에스 stock price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 녹십자엠에스 has recorded 23 reports. Market capitalisation: €52.1bn. The latest transaction was reported on 11 March 2026 (Purchase). Among the most active insiders: 녹십자엠에스. Every trade is openly available.
22
Insider Decl.
n/a
Thresholds
€5,192
14 ops.
Buy Volume
n/a
1 ops.
Sell Volume
31Σ signal
Buys €5,192n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,156 of 29,063 companies
52.7
score / 100
Value
63
Quality
43
FCF yld3.5%
Earn yld5.5%
EV/EBITDA9.6x
ROE9.9%
Gross mgn14%
Net mgn3.4%
Debt/EBITDA2.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.